A carregar...
Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas
The majority of historical therapies for managing T-cell lymphomas (TCLs) have consisted of T-cell–depleting strategies. Unfortunately, these forms of therapies can hamper the ability to mount effective antitumor immune responses. Recently, the use of checkpoint inhibitors has revolutionized the the...
Na minha lista:
| Publicado no: | Blood Adv |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7479955/ https://ncbi.nlm.nih.gov/pubmed/32898250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001966 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|